Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States
Abstract
Single‐institution studies have shown the oncologic benefit of ablative liver radiotherapy (A‐RT) for patients with unresectable intrahepatic cholangiocarcinoma (ICC). However, adoption of A‐RT across the United States and its associated outcomes are unknown.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Apr 13, 2022
- Source ID
- 10.1002/cncr.34223
Entities
People
- Albert C. Koong
- Brian De
- Bruce D. Minsky
- Ching‐wei D. Tzeng
- Cullen M. Taniguchi
- Emma B Holliday
- Ethan B Ludmir
- Eugene J Koay
- Gohar S. Manzar
- Grace L Smith
- Hop S Tran Cao
- J-N Vauthey
- Kanwal P S Raghav
- Kelsey L. Corrigan
- Milind Javle
- Prajnan Das
- Sunyoung S. Lee
Organizations
- National Cancer Institute
- National Institutes of Health
- RSNA Research and Education Foundation
- United States Department of Defense
- University of Texas at Austin